Application of genome-wide gene expression profiling by high-density DNA arrays to the treatment and study of inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 8, Issue 2, 2002, Pages 140-157

  Warner, Elaine E ^a   Dieckgraefe, Brian K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's disease; Gene expression; Inflammatory bowel disease; Microarry; Oligonucleotide arrays; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; COMPLEMENTARY DNA; COMPLEMENTARY RNA; GLASS; MERCAPTOPURINE; MESSENGER RNA; OLIGONUCLEOTIDE; SILICON; THIOPURINE METHYLTRANSFERASE;

ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DNA MICROARRAY; ENTERITIS; EXPRESSED SEQUENCE TAG; FLUORESCENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION SYSTEM; GENE TECHNOLOGY; HUMAN; IMMUNE RESPONSE; INFORMATION PROCESSING; MEDICAL GENETICS; MEDICAL RESEARCH; METHODOLOGY; MOLECULAR CLONING; MOLECULAR HYBRIDIZATION; PATHOGENESIS; PATIENT CODING; PRIORITY JOURNAL; ROBOTICS; SEQUENCE DATABASE; SIDE EFFECT;

EID: 0036198721     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200203000-00012     Document Type: Article

References (89)

1. Initial sequencing and analysis of the human genome
2. Generation and analysis of 280,000 human expressed sequence tags
3. Options available-from start to finish-for obtaining expression data by microarray
4. Exploring the new world of the genome with DNA microarrays
5. Making and reading microarrays
6. Expression profiling using cDNA microarrays
7. DNA arrays for analysis of gene expression
8. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays
9. Expression monitoring by hybridization to high-density oligonucleotide arrays
10. DNA chips: State-of-the-art
11. Parallel human genome analysis: Microarray-based expression monitoring of 1,000 genes
12. Genome-wide expression monitoring in Saccharomyces cerevisiae
13. Light-directed, spatially addressable parallel chemical synthesis
14. Going global: A note on nomenclature
15. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays
16. Ulcerative colitis and Crohn's disease: Distinctive gene expression profiles and novel susceptibility candidate genes
17. Microarrays: Their origins and applications
18. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
19. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer
20. Light-generated oligonucleotide arrays for rapid DNA sequence analysis
21. Using oligonucleotide probe arrays to access genetic diversity
22. Expression monitoring by hybridization to high-density oligonucleotide arrays
23. Genome-wide expression profiling in Escherichia coli K-12
24. Normalization and subtraction: Two approaches to facilitate gene discovery
25. Cloning of genes from single neurons
26. Genomics, gene expression and DNA arrays
27. A novel, sensitive detection system for high-density microarrays using dendrimer technology
28. Modulation of mRNA levels in the presence of thymocytes and genome mapping for a set of genes expressed in mouse thymic epithelial cells
29. Expression profiling in cancer using cDNA microarrays
30. Multiplex messenger assay: Simultaneous, quantitative measurement of expression of many genes in the context of T cell activation
31. Searching for evidence of altered gene expression: A comment on statistical analysis of microarray data
32. Computational methods for the identification of differential and coordinated gene expression
33. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray
34. Interactive visualization and exploration of relationships between biologic objects
35. Basic microarray analysis: Grouping and feature reduction
36. Analysis of large-scale gene expression data
37. Cluster analysis and display of genome-wide expression patterns
38. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
39. Analysis of gene expression data using self-organizing maps
40. Self-Organizing Maps
41. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays
42. The transcriptional program of sporulation in budding yeast
43. The transcriptional program in the response of human fibroblasts to serum
44. The complexity of radiation stress responses: Analysis by informatics and functional genomics approaches
45. Identification of genes expressed in human CD34(+) hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning
46. Detection and identification of previously unrecognized microbial pathogens
47. Molecular approaches for identification of infectious agents in Wegener's granulomatosis and other vasculitides
48. Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays
49. Interaction of Pseudomonas aeruginosa with epithelial cells: Identification of differentially regulated genes by expression microarray analysis of human cDNAs
50. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes
51. Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells
52. Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles
53. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
54. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis
55. Identification of a receptor for reg (regenerating gene) protein, a pancreatic beta-cell regeneration factor
56. Gene expression analysis as an aid to the identification of drug targets
57. Genomics and proteomics: The new millennium of drug discovery and development
58. DNA microarray technology and antimicrobial drug discovery
59. Genetic network inference: From co-expression clustering to reverse engineering
60. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization
61. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors
62. Functional discovery via a compendium of expression profiles
63. An information-intensive approach to the molecular pharmacology of cancer
64. Lessons from genetic models of inflammatory bowel disease
65. Experimental models of inflammatory bowel disease
66. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
67. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
68. Molecular profiling of clinical tissues specimens: Feasibility and applications
69. Molecular portraits of human breast tumors
70. Molecular classification of cutaneous malignant melanoma by gene expression profiling
71. Gene expression profiling with oligonucleotide microarrays distinguishes World Health Organization grade of oligodendrogliomas
72. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays
73. Crohn's disease: To lump or split?
74. Subgroups of patients with Crohn's disease have different clinical outcomes
75. Surgical recurrence of perforating and nonperforating Crohn's disease: A study of 101 surgically treated patients
76. Clinical pattern of corticosteroid dependent Crohn's disease
77. Molecular evidence for two forms of Crohn disease
78. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
79. Genetics of inflammatory bowel disease: Implications for the future
80. Genetics of inflammatory bowel disease
81. Population genetics-making sense out of sequence
82. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations
83. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
84. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
85. Gastrointestinal manifestations of chronic granulomatous disease
86. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden
87. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease
88. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
89. Gene-expression profiles in hereditary breast cancer